The total price cuts of the 6037 kinds of drugs in Jiangsu since September are nearly 10%

Business News Agency August 24 hearing Jiangsu Province Price Bureau yesterday announced the second batch of adjustment of the rate of increase in the price of 362 kinds of successful drugs, coupled with the previous announcement of 5,675 kinds, a total of 6037 kinds of drug specifications from September 1 different levels of price cuts. However, the reporter recently visited a number of social pharmacies but found that some drugs enter the hospital with a higher bid price than the retail price of pharmacies. Explain briefly: before entering public hospitals, the drugs first pass through the province’s bidding and determine a winning bid price. An increase of 15% on the basis of the price is the highest retail price of the hospital. However, if the bid price itself is higher than the retail price of the social pharmacy, then where can the drug price drop again?

6037 kinds of drug specifications from September

At the end of last month, a group announced, plus a batch announced yesterday, starting September 1, Jiangsu Province will have 6037 kinds of drug specifications to reduce the maximum retail price, the overall price reduction is close to 10%.

According to the Jiangsu Province Drug Concentration Bidding Regulations, the scope of “publicly-purchased-bidding-purchased medicines” refers to medicines in the directory of urban workers’ basic medical insurance (or publicly-funded medical) medicines and medical institutions that have relatively large clinical doses, that is, the amount of each purchase. Individual drugs below 50,000 yuan.” This also means that the price reduction of tender drugs will involve many commonly used drugs.

The reporter selected a number of commonly used drugs in the form announced by the price department, such as 0.5g*24 tablets in a box of Ganmaoling capsules, produced by Shaanxi Dongtai Pharmaceutical Co., Ltd., and the maximum retail price fell to 15 yuan, down by 1.3 yuan; 0.5 The highest retail price of g*36 film-coated Jiangzhong Jianwei Xiaoshi was 5.5 yuan, down by 0.96 yuan; 0.35g x 120 capsules, the highest retail price of Jinji capsule produced by Guangxi Lingfeng Pharmaceutical was 36.2 yuan, which was a drop of more than 3 yuan. The myopic eye drops made by Changchun Puhua Pharmaceutical also dropped from 48.2 yuan to 44.3 yuan. Reporter recently in the provincial hospital inquires through the electronic touch screen part of the price range included in the price of drugs, such as the price of Liu Wei Di Huang Wan is 12.6 yuan, in September will fall below 11.6 yuan, the current price of ibuprofen produced by China and the United States Shi Keke 16.5 yuan. After September, it will only sell for 15.2 yuan.

The price reduction is due to the drop in the rate of increase.

According to reports, on September 1 this year, the price of the large number of successful bid drugs has been reduced. One reason is that the rate of increase in drug prices has decreased.

At present, most of the public non-profit medical institutions at and above county level in Jiangsu Province and pharmaceuticals for designated medical institutions for basic medical insurance for urban workers are selected from the list of drug products that have been uniformly tendered in Jiangsu Province for centralized drug bidding. In the province's centralized tendering, the pharmaceutical manufacturer will determine the winning bid price through an agreement after winning the bid, and the so-called price increase rate refers to the maximum extent that the hospital can rise on the basis of the winning bid price when the successful bidder enters the hospital. For example, for medicines with a purchase price of 100 yuan, the rate of increase is 15%, and the maximum retail price in hospitals is 115 yuan.

Currently, drugs on the market in Jiangsu Province, according to the level of jurisdiction, the level of price, the implementation of a different rate of increase: the price of drugs belonging to the National Development and Reform Commission pricing 15% of the implementation of the rate of increase; Jiangsu Province Price Administration of drugs is divided into high and low prices, the bid price in The price increase rate is 10% and below 35%, the increase rate of 10.01-50 Yuan is 25%, the increase rate of 50.01-100 Yuan is 20%, the increase rate of 100.01-500 Yuan is 15%, and the maximum markup rate of 500 Yuan and above is not more than 75 yuan.

Starting from September 1, the rate of price increase for all winning drugs in addition to cheap drugs in Jiangsu is unified at 15%, which means that the maximum retail price of all drugs within 100 yuan will be slightly reduced.

Strange: Some of the winning bid prices are higher than the pharmacy retail price

The drug price dropped again. This is the Nth price cut from the country to the local drug. Although many patients feel that the expensive condition of the doctor is still the same, but for the 6037 kinds of drugs whose prices are to be reduced in September, the accounts of the price cuts are clearly published, and it is indeed a good thing.

However, the reporter recently visited a number of social pharmacies in Nanjing and found that not only did the price of most drugs fall after the price was announced in Jiangsu Province, their retail price was still higher than the price of social pharmacies, and even some drugs won the bid. The price itself is more expensive than the retail price of social pharmacies.

In a large pharmacy on Hanzhong Road in Nanjing, the reporter saw the price of tobramycin dexamethasone ointment from the United States Alcon being 27.5 yuan, while the bid price for public hospitals in Jiangsu Provincial Concentration Bidding reached 33.95 Yuan; There are adult-like Huifeining oral liquids, for example, the bid price in the centralized bidding in Jiangsu province is 15 yuan, but it only sells 14.8 yuan in pharmacies. There is such a situation, or else the pharmacy loses money to sell drugs, or else the purchase price of pharmacies is lower than that of Jiangsu Province. What kind of situation is it? In the face of reporters' questions, the person in charge of the relevant pharmacy is more cautious and does not want to say much. On the other hand, people in the price department said that the bid price is not determined by the price. What the Price Bureau has done is to calculate the maximum retail price strictly according to the markup rate and supervise the implementation of the hospital.

The reporter found that most of the price-reducing drugs, even after price cuts, have a higher retail price than the current price of some social pharmacies. For example, hydrocortisone butyrate produced by Hunan Nuodi Pharmaceutical Co., Ltd. sells 19.8 yuan in pharmacies, and the maximum retail price of the hospital is 22.5 yuan after the price reduction; the domperidone oral solution of Xi'an Janssen sells 12.8 yuan in pharmacies and the highest retail value in hospital after September. The price is 13.9 yuan; Jiangsu Kangyuan's Liuwei Dihuang soft capsule, the price of the pharmacy is 30.9 yuan, the highest retail price of the hospital after the price reduction is 31.4 yuan......

In response to this, some experienced citizens have come up with a solution that is to take a prescription in a hospital and then go to a pharmacy to take medicine. The reporter learned that at present, all major hospitals in Nanjing have implemented information management. Doctors will read out the sickness and prescribe a computer-printed prescription. If you think that medicine is too expensive, you may not be able to get the medicine in the hospital and go to the pharmacy to dispense medicine. It is a more cost-effective choice.